EHA 2023 Late-Breaking Abstracts Offer Sneak Peek at the Future of Hematology
The late-breaking oral session at the European Hematology Association (EHA) 2023 Congress featured newly emerged data from abstracts submitted after the deadline, including outcomes from trials in polycythemia vera, acute myeloid leukemia, and more.